{
  "id": 18042246,
  "title": "Alkermes reiterates $400M-$420M Q4 proprietary net sales outlook while targeting mid-2027 alixorexton Phase III data",
  "url": "https://urgent.news/2026/11/04/alkermes-reiterates-400m-420m-q4-proprietary-net-sales-outlook-while",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-11-04T00:17:44.000Z",
  "source": {
    "name": "Seeking Alpha News",
    "slug": "seeking-alpha-news",
    "url": "https://seekingalpha.com/news/4664357-alkermes-reiterates-400m-420m-q4-proprietary-net-sales-outlook-while-targeting-midminus-2027?feed_item_type=news"
  },
  "original_language": "en",
  "account": null,
  "summary": null,
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}